{"description":"Other Adverse Events summarizes the non-serious occurrences of adverse events that exceed the indicated frequency threshold.","eventGroups":[{"description":"Participants received blinatumomab by continuous intravenous (CIV) infusion over 4 weeks followed by a treatment-free interval of 2 weeks for 2 cycles. Participants who achieved a complete remission or complete remission with partial or incomplete hematologic recovery within 2 induction cycles of treatment could receive up to 3 additional consolidation cycles of blinatumomab.\n\nThe initial dose was 9 μg/day for the first 7 days of treatment, increased to 28 μg/day starting on day 8 and for all subsequent cycles of treatment.","id":"EG000","otherNumAffected":45,"otherNumAtRisk":45,"seriousNumAffected":28,"seriousNumAtRisk":45,"title":"Blinatumomab"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":45}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":45}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":45}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Tachycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":45}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":45}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Haemorrhoids"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":45}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":45}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":45}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Staphylococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Blood bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Blood calcium decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Hypoalbuminaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":45}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":45}],"term":"Bone pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":45}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Confusional state"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":45}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Hyperhidrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Petechiae"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":45}],"term":"Hypotension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":45}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":45}],"term":"Leukocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Lymph node pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Lymphoblastosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Pancytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Aplasia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Colitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Device infusion issue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Device malfunction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"General physical health deterioration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Multi-organ failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":45}],"term":"Non-cardiac chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":45}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Hepatic failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Acute graft versus host disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Catheter site infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Device related infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Lung infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Neutropenic sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Septic shock"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Femur fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Overdose"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Chest X-ray abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Arthritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Bone pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Aphasia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Cerebral haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Depressed level of consciousness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Encephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Hemiplegia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Spinal cord compression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":45}],"term":"Tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Alveolitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":45}],"term":"Pulmonary haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":45}],"term":"Respiratory failure"}],"timeFrame":"From the first dose of blinatumomab until 30 days after the last dose, up to the cut-off date of 20 May 2015; the median duration of treatment was 53.8 days."}